SCHEMBL756244

SCHEMBL756244

CS(=O)(=O)Nc1ccc2c(c1)OCC(=O)N2c1ccc(F)c(F)c1

nearest known ligand 0.80

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 6/20 0.53
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GFER P55789 1/20 0.40
PIK3CD O00329 3/20 0.38
SCN9A Q15858 3/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
PIK3R1 P27986 2/20 0.36
MTOR P42345 2/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL756352 0.90 NR3C2 (0.50) NR3C2MEN1KMT2APIK3CDGAA
SCHEMBL754538 0.84 NR3C2 (0.53) NR3C2PIK3CDSCN9AGAAHPGD
SCHEMBL755857 0.80 NR3C2 (0.80) NR3C2MEN1KMT2AGFERSCN9A
SCHEMBL756990 0.78 NR3C2 (0.56) NR3C2MEN1KMT2APIK3CDGAA
SCHEMBL753196 0.72 NR3C2 (0.77) NR3C2MEN1KMT2AADRA2CADRA1A
SCHEMBL755904 0.72 NR3C2 (0.77) NR3C2ADRA2CADRA1AADRA1B
SCHEMBL756833 0.71 NR3C2 (0.77) NR3C2MEN1KMT2ASCN9AADRA2C
SCHEMBL756315 0.71 NR3C2 (0.75) NR3C2ADRA2CADRA1AADRA1B
SCHEMBL753564 0.71 NR3C2 (0.75) NR3C2GAAHPGDMAPK1ADRA2C
SCHEMBL743757 0.71 NR3C2 (0.75) NR3C2MEN1KMT2AGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984345-B9 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS MITSUBISHI TANABE PHARMA CORP (JP) 2012-03-21 EP claimed
EP-1984345-B1 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS MITSUBISHI TANABE PHARMA CORP (JP) 2011-08-31 EP claimed